Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Plants (Basel) ; 11(17)2022 Aug 24.
Artículo en Inglés | MEDLINE | ID: mdl-36079576

RESUMEN

Medicinal properties of plants are usually identified based on knowledge of traditional medicine or using low-throughput screens for specific pharmacological activities. The former is very biased since it requires prior knowledge of plants' properties, while the latter depends on a specific screening system and will miss medicinal activities not covered by the screen. We sought to enrich our understanding of the biological activities of Sarcopoterium spinosum L. root extract based on transcriptome changes to uncover a plurality of possible pharmacological effects without the need for prior knowledge or functional screening. We integrated Gene Set Enrichment Analysis of the RNAseq data to identify pathways affected by the treatment of cells with the extract and perturbational signatures in the CMAP database to enhance the validity of the results. Activities of signaling pathways were measured using immunoblotting with phospho-specific antibodies. Mitochondrial membrane potential was assessed using JC-1 staining. SARS-CoV-2-induced cell killing was assessed in Vero E6 and A549 cells using an MTT assay. Here, we identified transcriptome changes following exposure of cultured cells to the medicinal plant Sarcopoterium spinosum L. root extract. By integrating algorithms of GSEA and CMAP, we confirmed known anti-cancer activities of the extract and predicted novel biological effects on oxidative phosphorylation and interferon pathways. Experimental validation of these pathways uncovered strong activation of autophagy, including mitophagy, and excellent protection from SARS-CoV-2 infection. Our study shows that gene expression analysis alone is insufficient for predicting biological effects since some of the changes reflect compensatory effects, and additional biochemical tests provide necessary corrections. This study defines the advantages and limitations of transcriptome analysis in predicting the biological and medicinal effects of the Sarcopoterium spinosum L. extract. Such analysis could be used as a general approach for predicting the medicinal properties of plants.

2.
BMJ Case Rep ; 13(9)2020 Sep 23.
Artículo en Inglés | MEDLINE | ID: mdl-32967944

RESUMEN

The present case report describes a 65-year-old man with Lynch syndrome and hypercalcaemia associated with hyperparathyroidism. Parathyroid surgery confirmed the diagnosis of parathyroid carcinoma. Serum calcium and parathyroid hormone (PTH) concentrations serially increased after initial surgery. Imaging study and subsequent biopsy confirmed lung metastases with mismatch repair deficiency. Pembrolizumab was initiated achieving 60% reduction in tumour burden.


Asunto(s)
Anticuerpos Monoclonales Humanizados/uso terapéutico , Neoplasias Colorrectales Hereditarias sin Poliposis/complicaciones , Neoplasias Pulmonares/tratamiento farmacológico , Inestabilidad de Microsatélites , Neoplasias de las Paratiroides/terapia , Anciano , Biomarcadores de Tumor/genética , Biopsia , Calcio/sangre , Quimioterapia Adyuvante/métodos , Neoplasias Colorrectales Hereditarias sin Poliposis/sangre , Neoplasias Colorrectales Hereditarias sin Poliposis/genética , Neoplasias Colorrectales Hereditarias sin Poliposis/terapia , Análisis Mutacional de ADN , Humanos , Hipercalcemia/diagnóstico , Hipercalcemia/genética , Hipercalcemia/terapia , Hiperparatiroidismo/diagnóstico , Hiperparatiroidismo/genética , Hiperparatiroidismo/terapia , Pulmón/diagnóstico por imagen , Pulmón/patología , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/secundario , Masculino , Glándulas Paratiroides/diagnóstico por imagen , Glándulas Paratiroides/patología , Glándulas Paratiroides/cirugía , Hormona Paratiroidea/sangre , Neoplasias de las Paratiroides/diagnóstico , Neoplasias de las Paratiroides/genética , Neoplasias de las Paratiroides/patología , Paratiroidectomía , Tomografía Computarizada por Tomografía de Emisión de Positrones , Receptor de Muerte Celular Programada 1/antagonistas & inhibidores , Tomografía Computarizada de Emisión de Fotón Único , Resultado del Tratamiento , Secuenciación del Exoma
3.
Cell Rep ; 13(11): 2553-2564, 2015 Dec 22.
Artículo en Inglés | MEDLINE | ID: mdl-26686638

RESUMEN

We evaluated the mechanism by which neutralizing human monoclonal antibodies inhibit chikungunya virus (CHIKV) infection. Potently neutralizing antibodies (NAbs) blocked infection at multiple steps of the virus life cycle, including entry and release. Cryo-electron microscopy structures of Fab fragments of two human NAbs and chikungunya virus-like particles showed a binding footprint that spanned independent domains on neighboring E2 subunits within one viral spike, suggesting a mechanism for inhibiting low-pH-dependent membrane fusion. Detailed epitope mapping identified amino acid E2-W64 as a critical interaction residue. An escape mutation (E2-W64G) at this residue rendered CHIKV attenuated in mice. Consistent with these data, CHIKV-E2-W64G failed to emerge in vivo under the selection pressure of one of the NAbs, IM-CKV063. As our study suggests that antibodies engaging the residue E2-W64 can potently inhibit CHIKV at multiple stages of infection, antibody-based therapies or immunogens that target this region might have protective value.


Asunto(s)
Anticuerpos Monoclonales/inmunología , Anticuerpos Neutralizantes/inmunología , Virus Chikungunya/metabolismo , Epítopos/inmunología , Animales , Artritis/metabolismo , Artritis/patología , Quimiocinas/análisis , Virus Chikungunya/genética , Virus Chikungunya/patogenicidad , Chlorocebus aethiops , Citocinas/análisis , Modelos Animales de Enfermedad , Mapeo Epitopo , Genotipo , Humanos , Fusión de Membrana , Ratones , Ratones Endogámicos C57BL , Simulación de Dinámica Molecular , Mutagénesis Sitio-Dirigida , Estructura Cuaternaria de Proteína , Células Vero , Proteínas del Envoltorio Viral/genética , Proteínas del Envoltorio Viral/metabolismo , Internalización del Virus
4.
Curr Opin Pediatr ; 26(2): 146-50, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24503532

RESUMEN

PURPOSE OF REVIEW: There is an intense interest among neonatal caregivers as to whether lactoferrin given enterally may reduce the incidence of necrotizing enterocolitis in preterm infants. This review presents scientific and clinical evidence that lactoferrin alleviates or prevents this life-threatening disease. RECENT FINDINGS: Preclinical studies in neonatal rats showed that lactoferrin given orally before enteral infection with pathogenic Escherichia coli reduced bacteremia and mortality. A multicentered clinical trial found that very low-birth weight preterm infants given bovine lactoferrin had a significant reduction in late-onset sepsis; there was also a trend towards a diminished incidence of necrotizing enterocolitis. Although multicentered trials of lactoferrin use in preterm infants are near completion, regulatory burdens required to bring lactoferrin to the bedside may limit its availability. SUMMARY: Extremely preterm infants should receive colostrum, a natural lactoferrin concentrate, immediately after birth and, ideally, continue on breast milk throughout the hospital stay. This practice appears well tolerated, but additional experience will tell us whether this practice reduces the prevalence of necrotizing enterocolitis.


Asunto(s)
Calostro , Enterocolitis Necrotizante/prevención & control , Tracto Gastrointestinal/inmunología , Inflamación/inmunología , Lactoferrina/uso terapéutico , Sepsis/prevención & control , Animales , Nutrición Enteral , Enterocolitis Necrotizante/inmunología , Humanos , Inmunidad Innata , Incidencia , Recién Nacido , Recien Nacido Prematuro , Enfermedades del Prematuro/prevención & control , Recién Nacido de muy Bajo Peso , Lactoferrina/administración & dosificación , Lactoferrina/inmunología , Ensayos Clínicos Controlados Aleatorios como Asunto , Sepsis/inmunología
5.
JPEN J Parenter Enteral Nutr ; 38(6): 711-6, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23963690

RESUMEN

BACKGROUND: Preliminary studies suggest that fish-oil lipid emulsion given parenterally to very preterm infants reduces the severity of retinopathy (ROP) and cholestasis. METHODS: Infants weighing <1250 g at birth were randomly allocated to 2 groups: an experimental group of 60 infants that received an intravenous (IV) soybean, olive oil, and fish oil emulsion, and a control group of 70 infants that was given a parenteral soybean and olive oil emulsion. Plasma and erythrocyte concentrations of docosahexaenoic acid (DHA) were determined using a high-performance liquid chromatography-mass spectrometry analysis. RESULTS: Nine infants in the fish oil group required laser therapy for ROP compared with 22 infants in the standard intralipid group (risk ratio [RR], 0.48; 95% confidence interval [CI], 0.24-0.96). Three infants in the fish oil group developed cholestasis compared with 20 infants in the standard intralipid group (RR, 0.18; 95% CI, 0.055-0.56). The mean plasma DHA concentrations in treated infants were 2.9-fold higher in the fish oil group than in control infants on the 7th and 14th days of life. The mean DHA content in erythrocytes of treated infants was 4.5-fold and 2.7-fold higher compared with controls at 7 and 14 days of age. CONCLUSIONS: Premature infants receiving an IV fat emulsion containing fish oil had less ROP requiring laser treatment and less cholestasis than those receiving a standard lipid emulsion. These infants also had higher plasma and erythrocyte DHA levels at 7 and 14 days, suggesting potential long-term neurodevelopmental benefits.


Asunto(s)
Emulsiones Grasas Intravenosas/uso terapéutico , Aceites de Pescado/uso terapéutico , Recién Nacido de muy Bajo Peso , Retinopatía de la Prematuridad/prevención & control , Desarrollo Infantil/efectos de los fármacos , Colestasis/sangre , Colestasis/prevención & control , Ácidos Docosahexaenoicos/sangre , Ácidos Docosahexaenoicos/uso terapéutico , Emulsiones/uso terapéutico , Femenino , Humanos , Recién Nacido , Recien Nacido Prematuro , Masculino , Aceite de Oliva , Nutrición Parenteral/métodos , Fosfolípidos/uso terapéutico , Aceites de Plantas/uso terapéutico , Estudios Prospectivos , Retinopatía de la Prematuridad/sangre , Aceite de Soja/uso terapéutico , Resultado del Tratamiento
6.
Clin Perinatol ; 40(1): 79-91, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23415265

RESUMEN

Lactoferrin (LF) is a multifunctional protein and a member of the transferrin family. LF and lysozyme in breast milk kill bacteria. In the stomach, pepsin digests and releases a potent peptide antibiotic called lactoferricin from native LF. The antimicrobial characteristics of LF may facilitate a healthy intestinal microbiome. LF is the major whey in human milk; its highest concentration is in colostrum. This fact highlights early feeding of colostrum and also fresh mature milk as a way to prevent necrotizing enterocolitis.


Asunto(s)
Calostro/metabolismo , Enterocolitis Necrotizante/prevención & control , Intestino Delgado/inmunología , Lactoferrina/metabolismo , Leche Humana/metabolismo , Animales , Calostro/inmunología , Enterocolitis Necrotizante/terapia , Humanos , Recién Nacido , Intestino Delgado/microbiología , Lactoferrina/inmunología , Lactoferrina/uso terapéutico , Metagenoma/inmunología , Leche/metabolismo , Leche Humana/química , Leche Humana/inmunología , Muramidasa/inmunología
8.
Stat Med ; 28(24): 2952-66, 2009 Oct 30.
Artículo en Inglés | MEDLINE | ID: mdl-19691023

RESUMEN

The analysis of data from matched pairs binary experiments, often performed with McNemar's test, presents a unique experimental design challenge in dealing with the effect of the discordance probability, p. Most approaches for determining size and power use point estimates or maximization, but this fails to account for the considerable variability across values of the nuisance parameter that occur for all common tests. We recommend viewing the size and power functions across the full range of possible discordance probability values, which gives a complete picture of the behavior of a test for any given sample size. This method also allows us to compare the behavior of different hypothesis tests. We present exact power and size functions for several tests, including the original McNemar's test and its most common variants, and compare their properties. This analysis reveals that, in general, McNemar's test comes closest to the nominal size and has the highest power. We also demonstrate our technique using the transmission/disequilibrium test (TDT) to check for linkage between schizophrenia and a locus related to the D(3) dopamine receptor, and on a hypnosis pain management data set.


Asunto(s)
Bioestadística/métodos , Análisis por Apareamiento , Modelos Estadísticos , Algoritmos , Distribución Binomial , Humanos , Hipnosis , Desequilibrio de Ligamiento , Neoplasias/complicaciones , Neoplasias/terapia , Dolor/etiología , Manejo del Dolor , Receptores de Dopamina D3/genética , Tamaño de la Muestra , Esquizofrenia/genética , Programas Informáticos
9.
J Pediatr Gastroenterol Nutr ; 48(2): 216-25, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19179885

RESUMEN

OBJECTIVE: To compare the effect of 2 prebiotic/probiotic products on weight gain, stool microbiota, and stool short-chain fatty acid (SCFA) content of premature infants. PATIENTS AND METHODS: This randomized, blinded, placebo-controlled trial included 90 premature infants treated with either a dietary supplement containing 2 lactobacillus species plus fructooligosaccharides (CUL, Culturelle, ConAgra, Omaha, NE), a supplement containing several species of lactobacilli and bifidobacteria plus fructooligosaccharides (PBP, ProBioPlus DDS, UAS Laboratories, Eden Prairie, MN), or placebo (a dilute preparation of Pregestamil formula) twice daily for 28 days or until discharge if earlier. The primary outcome was weight gain. Secondary outcomes were stool bacterial analysis by culture and 16S rDNA quantitative polymerase chain reaction and stool SCFA content measured by high performance liquid chromatography. RESULTS: Both prebiotic/probiotic combinations contained more bacterial species than noted on the label. No significant effect on infant growth of either prebiotic/probiotic supplement was observed. By cultures, 64% of infants receiving PBP became colonized with bifidobacteria, compared with 18% of infants receiving CUL and 27% of infants receiving placebo (chi-square, P = 0.064). No differences were noted between groups in colonization rates for lactobacilli, Gram-negative enteric bacteria, or staphylococci. By 16S rDNA polymerase chain reaction analysis, the bifidobacteria content in the stools of the infants receiving PBP was higher than in the infants receiving CUL or placebo (Kruskal-Wallis, P = 0.011). No significant differences in stool SCFA content were detected between groups. No adverse reactions were noted. CONCLUSIONS: Infants receiving PBP were more likely to become colonized with bifidobacteria. No significant differences in weight gain or stool SCFA content were detected.


Asunto(s)
Bifidobacterium/crecimiento & desarrollo , Ácidos Grasos Volátiles/análisis , Tracto Gastrointestinal/microbiología , Recien Nacido Prematuro/crecimiento & desarrollo , Oligosacáridos/administración & dosificación , Probióticos/administración & dosificación , Aumento de Peso , Administración Oral , Cromatografía Líquida de Alta Presión , Recuento de Colonia Microbiana , Heces/química , Heces/microbiología , Femenino , Edad Gestacional , Humanos , Recién Nacido , Lactobacillus/crecimiento & desarrollo , Masculino , Reacción en Cadena de la Polimerasa , Factores de Tiempo , Resultado del Tratamiento
10.
J Endod ; 34(6): 656-9, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18498883

RESUMEN

The aim of this randomized, double-blinded study was to compare the anesthetic efficacy of 4% articaine with 1:100,000 epinephrine (AE) with 2% lidocaine with 1:100,000 epinephrine (LE) for Gow-Gates blocks and maxillary infiltrations in patients experiencing irreversible pulpitis in mandibular and maxillary posterior teeth. Forty patients diagnosed with irreversible pulpitis of a posterior tooth randomly received either AE or LE by using a Gow-Gates injection or maxillary infiltration. Endodontic access was initiated after no response to Endo-ice 15 minutes after solution deposition. Success was defined as none to mild pain on a visual analogue scale after access. Chi-square and analysis of variance statistical tests were used to analyze the data. Successful endodontic treatment substantially reduced the assessment of pulpitis pain by patients (analysis of variance, P < .0001). Overall anesthetic success in both dental arches was 87.5%. Anesthetic success was not influenced by tooth arch (chi(2), P > .7515) or gender (chi(2), P > .1115). AE proved to be as effective but not superior to LE (P > .6002). These results demonstrated the similar anesthetic effectiveness of AE and LE when used during the endodontic treatment of teeth diagnosed with irreversible pulpitis.


Asunto(s)
Anestesia Dental/métodos , Anestesia Local/métodos , Anestésicos Locales/administración & dosificación , Carticaína/administración & dosificación , Lidocaína/administración & dosificación , Bloqueo Nervioso/métodos , Pulpitis/terapia , Distribución de Chi-Cuadrado , Método Doble Ciego , Femenino , Humanos , Inyecciones , Masculino , Nervio Mandibular , Diente Molar , Dimensión del Dolor , Estudios Prospectivos , Análisis de Regresión , Tratamiento del Conducto Radicular , Estadísticas no Paramétricas
11.
Autism ; 10(4): 317-29, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16908476

RESUMEN

LEGO building materials have been adapted as a therapeutic modality for increasing motivation to participate in social skills intervention, and providing a medium through which children with social and communication handicaps can effectively interact. A 3 year retrospective study of long-term outcome for autistic spectrum children participating in LEGO therapy (N = 60) compared Vineland Adaptive Behavior Scale socialization domain (VABS-SD) and Gilliam Autism Rating Scale social interaction subscale (GARS-SI) scores preand post-treatment with a matched comparison sample (N = 57) who received comparable non-LEGO therapy. Although both groups made significant gains on the two outcome measures, LEGO participants improved significantly more than the comparison subjects. Diagnosis and pre-treatment full-scale IQ scores did not predict outcome scores; however, Vineland adaptive behavior composite, Vineland communication domain, and verbal IQ all predicted outcome on the VABS-SD, especially for the LEGO therapy group. Results are discussed in terms of implications for methods of social skills intervention for autistic spectrum disorders.


Asunto(s)
Trastorno Autístico/psicología , Relaciones Interpersonales , Trastornos Mentales/etiología , Trastornos Mentales/terapia , Ludoterapia , Conducta Social , Antipsicóticos/uso terapéutico , Estimulantes del Sistema Nervioso Central/uso terapéutico , Niño , Terapia Combinada , Femenino , Humanos , Masculino , Psicoterapia de Grupo , Inhibidores Selectivos de la Recaptación de Serotonina/uso terapéutico , Ajuste Social , Socialización , Logopedia , Factores de Tiempo
12.
J Org Chem ; 70(16): 6474-83, 2005 Aug 05.
Artículo en Inglés | MEDLINE | ID: mdl-16050712

RESUMEN

We have accomplished the synthesis of a complex chemical library via elaboration of angular epoxyquinol scaffolds with distinct skeletal frameworks. The key strategy involves highly stereocontrolled [4 + 2] Diels-Alder cycloadditions of chiral, nonracemic epoxyquinol dienes to generate the scaffolds. Further scaffold diversification involves hydrogenation, epimerization, dehydration, and condensation of the carbonyl group with alkoxyamine and carbazate building blocks. Further elaboration of the scaffolds also provided new skeletal frameworks using hydroxyl-directed Diels-Alder cycloaddition and reductive N-N bond cleavage. The overall process afforded 244 highly complex and functionalized compounds. Preliminary biological screening of the library uncovered six compounds which showed significant inhibition of Hsp 72 induction.


Asunto(s)
Evaluación Preclínica de Medicamentos/instrumentación , Evaluación Preclínica de Medicamentos/métodos , Compuestos Epoxi/química , Compuestos Epoxi/síntesis química , Hidroquinonas/química , Hidroquinonas/síntesis química , Compuestos Epoxi/farmacología , Proteínas del Choque Térmico HSP72 , Proteínas de Choque Térmico/antagonistas & inhibidores , Proteínas de Choque Térmico/metabolismo , Hidroquinonas/farmacología , Hidroxilación , Maleimidas/química , Estructura Molecular , Protones , Estereoisomerismo , Triazoles/síntesis química , Triazoles/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA